Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more
Plus de USD 6 millions de dollars du Fonds Humanitaire pour la crise de Djugu
Plus de 67 000 enfants ciblés par une vaccination contre la rougeole en Ituri
Lutte difficile pour endiguer la rougeole dans le sud-est
Persistence de l'insécurité, mouvements continus de civils
...Appui d’urgence à l’ éducation à Nobili, Nord-Kivu
more
Just 15 weeks into 2019, more measles outbreaks have been declared in South Sudan than occurred in all of 2018. As of Wednesday, 10 April, there had been 11 active outbreaks and four deaths had been confirmed. Another two deaths are suspected cases of measles. Earlier this year a campaign to vaccina...te children across South Sudan was delayed due to a shortage of vaccines and funding
more
The Department of Health (DOH) today requested the National Disaster Risk Reduction and Management Council Chair Secretary Delfin N. Lorenzana to convene a full council meeting and declared a national dengue epidemic in the wake of the 146,062 cases recorded since January up to July 20 this year, 98...% higher than the same period in 2018. There were 622 deaths.
more
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a...s the protocol provided here, epidemiological exposure data and biological samples can be systematically collected and shared rapidly in a format that can be easily aggregated, tabulated and analyzed across many different settings globally for timely estimates of 2019-nCoV infection severity and transmissibility, as well as to inform public health responses and policy decisions. This is particularly important in the context of a novel respiratory pathogen, such as 2019-nCoV
more
The household transmission investigation is a case-ascertained prospective study of all identified household contacts of a laboratory confirmed 2019-nCoV infection (see 2.2 Study population). It is intended to provide rapid and early information on the clinical, epidemiological and virological chara...cteristics of 2019-nCoV.
There are three primary objectives of this household transmission study:
To better understand the extent of transmission within a household by estimating the secondary infection rate for household contacts at an individual level, and factors associated with any variation in the secondary infection risk.
To characterize secondary cases including the range of clinical presentation, risk factors for infection, and the extent and fraction of asymptomatic infections.
To characterize serologic response following confirmed 2019-nCoV infection (highly encouraged, but optional depending on laboratory capacity and resources)
more
Sie können auf der Seite des RKI auch Informationen in Chinesisch, Koreanisch und Persisch herunterladen
https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Transport/Info_Reisende_Tab.html
The aim of this document is to support public health preparedness planning with regard to personal protective equipment (PPE) needs in healthcare settings where patients suspected or confirmed to have been infected with the novel coronavirus 2019-nCoV are being treated.
O Coronavírus1 está se espalhando globalmente. Como podem os indivíduos, comunidades e agentes humanitários responderem ao surto do COVID-19? Como o Manual Esfera pode orientar essa resposta?
22 février 2020 Addis-Abeba, Éthiopie
Interim Framework for the South-East Asia Region 28 October 2020